gms | German Medical Science

73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

29.05. - 01.06.2022, Köln

Resilience in lower grade glioma patients

Resilienz bei Patienten mit niedergradigen Gliomen

Meeting Abstract

  • presenting/speaker Jan Coburger - Universitätsklinik Ulm am Standort Günzburg, Klinik für Neurochirurgie, Günzburg, Deutschland
  • presenting/speaker Ellen Fröhlich - Universitätsklinik Ulm am Standort Günzburg, Klinik für Neurochirurgie, Günzburg, Deutschland
  • Minou Nadji-Ohl - Klinikum Stuttgart, Katharinenhospital, Neurochirurgische Klinik, Stuttgart, Deutschland
  • Meike Unteroberdörster - Charité – Universitätsmedizin Berlin, Klinik für Neurochirurgie, Berlin, Deutschland
  • Stefan Rückriegel - Universitätsklinikum Würzburg, Neurochirurgische Klinik und Poliklinik, Würzburg, Deutschland
  • Christian von der Brelie - Universitätsmedizin Göttingen, Neurochirurgische Klinik, Göttingen, Deutschland
  • Constantin Roder - Universitätsklinikum Tübingen, Klinik für Neurochirurgie, Tübingen, Deutschland
  • Marie-Thérèse Forster - Universitätsklinikum Frankfurt, Frankfurt a. M., Deutschland
  • Stefan Schommer - Klinikum Stuttgart, Katharinenhospital, Neurochirurgische Klinik, Stuttgart, Deutschland
  • Mario Löhr - Universitätsklinikum Würzburg, Neurochirurgische Klinik und Poliklinik, Würzburg, Deutschland
  • Andrej Pala - Universitätsklinik Ulm am Standort Günzburg, Klinik für Neurochirurgie, Günzburg, Deutschland
  • Simone Goebel - Universitätsklinikum Schleswig-Holstein, Campus Kiel, Neuropsychologie, Kiel, Deutschland
  • Julia Sophie Onken - Charité – Universitätsmedizin Berlin, Klinik für Neurochirurgie, Berlin, Deutschland
  • Christian Rainer Wirtz - Universitätsklinik Ulm am Standort Günzburg, Klinik für Neurochirurgie, Günzburg, Deutschland
  • Marcus Czabanka - Universitätsklinikum Frankfurt, Frankfurt a. M., Deutschland
  • Marcos Tatagiba - Universitätsklinikum Tübingen, Klinik für Neurochirurgie, Tübingen, Deutschland
  • Veit Rohde - Universitätsmedizin Göttingen, Neurochirurgische Klinik, Göttingen, Deutschland
  • Ralf-Ingo Ernestus - Universitätsklinikum Würzburg, Neurochirurgische Klinik und Poliklinik, Würzburg, Deutschland
  • Peter Vajkoczy - Charité – Universitätsmedizin Berlin, Klinik für Neurochirurgie, Berlin, Deutschland
  • Oliver Ganslandt - Klinikum Stuttgart, Katharinenhospital, Neurochirurgische Klinik, Stuttgart, Deutschland
  • Mirjam Renovanz - Universitätsklinikum Tübingen, Klinik für Neurochirurgie, Tübingen, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie. Köln, 29.05.-01.06.2022. Düsseldorf: German Medical Science GMS Publishing House; 2022. DocV137

doi: 10.3205/22dgnc137, urn:nbn:de:0183-22dgnc1370

Veröffentlicht: 25. Mai 2022

© 2022 Coburger et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Current data shows that resilience is an important factor in cancer patients’ well-being. It may positively influence patients’ psycho-oncological distress. Resilience is often referred to as the ability to withstand external or internal stress and can be therapeutically empowered. In the current study we aim to explore resilience of patients with lower grade glioma (LGG) and their potential influencing factors.

Methods: We performed a cross-sectional assessment of adult patients with astrocytoma or oligodendroglioma of WHO grade II & III prospectively enrolled in the LoG-Glio registry. By phone interview we assessed resilience scale (RS-13), distress thermometer (DT), MOCA (Montreal cognitive assessment) phone, internalized stigma of mental illness (ISMI), Eastern oncology group performance status (ECOG), pain scale. Typical clinical parameters as adjuvant treatment, occupational and relationship status were assessed. We performed an explorative assessment. Correlations were assessed by Spearman’s ρ.

Results: We included 74 patients. Median age was 41 years (Min 21, max 67). Median time since diagnosis was 4 years (min 1, max 13). 32 patients (43%) had a radiation therapy (RT) with consecutive chemotherapy (CT), one patient RT only and 9 patients had CT only. 28 patients (38%) showed a low, 16 (22%) a moderate and 30 (41%) a high resilience. Overall 29 patients (40%) had a pathological DT. In patients with low resilience pathological DT rate was 50%, in moderate resilience 44% and in high resilience 27%. In patients with low resilience, 50% had subnormal MOCA scores, while in moderate and high resilience it was found in 13% and 27%, only. We found significant correlations of resilience with distress (p<0.01, -.43), MOCA (p=0.039, .24), ECOG (p<0.01, -.49), stigmatization (p=0.012, -2.9), pain (p<0.01, -.47), care level (p=0.001, -.38) and occupation (p=0.01, .31). No correlations were found for education, sex, age and time since diagnosis. Even though, distress and resilience correlate with each other, distress did not correlate with occupation or care level, while relationship status only correlated with distress (p=0.01, .29).

Conclusion: In LGG psycho-oncological distress is a relevant and often underestimated burden. It significantly correlates with patients' resilience. Many of the influencing factors of resilience can be leveraged. Especially, pain, low functional status, stigmatization and occupation should be identified and targeted in the clinical routine.